CTA highlights the best articles from the month of July 2018
- Industry Viewpoints: Effectively Outsourcing Early Phase Clinical Trials
- The Top 5: July 2018
- Biopharmaceuticals and the DACH Region: The Availability of Patients in Austria, Germany and Switzerland
- Industry Viewpoints: The Pivotal Role of Skilled and Experienced Data Managers in Clinical Trials
- Industry Viewpoints: Adopting a Data-Driven Approach to Monitoring
Industry Viewpoints: Effectively Outsourcing Early Phase Clinical Trials
CTA’s Elizabeth Williams catches up with Jeffrey Hausfeld, CMO, BioFactura, on the complexities of carrying out early phase studies
Biopharmaceuticals and the DACH Region: The Availability of Patients in Austria, Germany and Switzerland
CTA’s Adeola Coker explores why patient recruitment remains a challenge in the DACH region
Industry Viewpoints: Strategic Overview and Risk Management in Clinical Operations
Dr Joachim Luithle, VP, Head Clinical Development Operations, Bayer, speaks to CTA’s Adeola Coker about risk management in clinical operations
The Brexit Countdown: Is there still an Opportunity for Conducting Clinical Trials in the UK?
Malcolm Thomas, Agile Sciences Inc., debates some of the regulatory challenges that Brexit may pose for those companies seeking to initiate clinical trials in the U.K.
Expert Insights: The Post-Brexit Era – Will the U.K. become a Second-Tier State?
Alexandra Annis, MS, Senior Immunology Analyst, GlobalData, examines the BEIS’ recent report on the implications of Brexit on the pharmaceutical industry
Increasing Transparency and Building Relationships between Sponsors and CROs
Jacqueline Mardell, VP Clinical Operations, Ascendis Pharma, examines ways in which sponsors and CROs can work together more seamlessly
Read our magazine
Global Defence Technology is the essential reading material for decision-makers in the defence industry, bringing you the latest news and analysis in an exciting, interactive format.